Our research projects

Attacking the roots of AML

In some cases of AML, people can see their disease return. This is because some cells get left behind despite treatment. Professor Bertie Göttgens wants to understand more about this and find new ways to treat the disease.

Repurposing drugs to treat acute myeloid leukaemia

Blood Cancer UK's researchers look at whether existing drugs for solid tumours can treat AML. This could provide a new option for people with the disease.

Understanding changes in AML stem cells - Professor Constanze Bonifer

Find out more about Professor Constanze Bonifer's research into alterations in genes of Acute myeloid leukaemia (AML) cells, to find new ways to treat the blood cancer.

Understanding whether we can prevent acute myeloid leukaemia- Professor George Vassiliou

Find out more about Professor George Vassiliou's study into preventing people from developing acute myeloid leukaemia (AML), by seeing if DNMT3A is responsible for cells becoming ‘pre-leukaemic'.

Finding new ways to treat AML - Professor Alex Tonks

Professor Tonks is studying what drives AML to try and find new treatment targets for people the disease.

Understanding what causes relapse in people with AML - Professor Dominique Bonnet

In this project, Professor Bonet wants to understand more about the cell that she thinks is responsible for AML returning.

Finding new ways to treat acute myeloid leukaemia - Dr Neil Rodrigues

In this project, Dr Rodrigues is trying to find new ways to treat AML.

Understanding more about the alterations in our cells that can cause myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML)

Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are both types of blood cancer that can occur when the process which repairs damaged blood cells goes wrong. Dr Quek wants to understand more about this to develop better treatments for people with these diseases.

Understanding how we could make better drug treatments to target acute myeloid leukaemia (AML)

Dr Payne wants to understand more about a specific alteration that causes acute myeloid leukaemia (AML), to help develop new, more effective drug treatments with fewer side effects.

Creating new ways to prevent the development of myeloid blood cancers

Professor Vassiliou wants to understand how myeloid cancers develop before people start showing any symptoms to create new ways to prevent people developing these blood cancers.

Unlocking a new, less harmful way of treating acute myeloid leukaemia (AML) - Professor Lacaud

Professor Lacaud's research is looking to understand more about the KAT6A protein and how it could be used as a kinder treatment for acute myeloid leukaemia (AML).